Introduction: Allergic rhinitis (AR) is a non-infectious disorder of the upper respiratory system that is recognized by nasal obstruction, nasal itching, sneezing, and rhinorrhea induced by inhaled allergens and involves mucosal inflammation. Despite various medicines are available to manage AR but not all have been shown to be effective in all patients, and thus necessitating the development of innovative therapeutics. Objectives: This study was designed to measure the serum levels of IL-22 and IL-35 in Allergic Rhinitis patients and assessing their correlation with disease severity. Materials and Methods: This study included 48 patients with AR and 42 healthy controls. IL-35 and IL-22 were measured using ELAISA kits while the Allergic sensitization of patients was demonstrated by measuring IgE and Eosinophil count. Severity scores of AR patients were calculated using ARIA's recommendations for Total Nasal Symptoms Score (TNSS). The AR patients were divided into three groups based on these scores: mild (n=16), moderate (n=12), and severe (n=20). Results: Serum levels of IL-35 and IL-22 were compared between AR patients and control group: IL-22 was indicated as higher (P=0.0001) in AR patients while the levels of IL-35 detected an inverse result as being lower (P=0.037) in AR patients than control group.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.